A novel lattice technique via adaptive spot assignment and LET optimization based proton arc therapy
In brief
Proton lattice technique doubles peak-valley dose ratio and cuts delivery time by one-third
The new adaptive spot-assignment and LET-optimized proton arc plan raised the peak-valley dose ratio from about 17 to 42, while shortening beam delivery by roughly 37% and reducing required spots by 94%. Phantom tests confirmed accurate delivery, suggesting the method could make proton lattice radiotherapy more practical, though clinical outcomes remain to be studied.
- Journal
- International journal of radiation oncology, biology, physics (Q1)
- Published
- 15 August 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Yujia Qian, Yajun Jia, Qingkun Fan, Lewei Zhao, Riao Dao, Tianyang Li, et al.
- PMID
- 42603564
- DOI
- 10.1016/j.ijrobp.2026.07.051
Why clinicians should know about it
- Picked for Medical Physics (top studies of the week, 16 August 2026): Improved PVDR and LET, phantom-validated proton arc
Abstract
PURPOSE: Lattice radiation therapy is an innovative three-dimensional implementation of spatially fractionated radiation therapy. This study aimed to develop a novel lattice-based proton arc therapy (PAT) technique to deliver a highly modulated peak-valley spatial dose distribution and a modulated linear energy transfer (LET) distribution. METHODS AND MATERIALS: We introduced a PAT lattice algorithm that optimizes three key components, including energy-layer selection, spot assignment, and LET optimization (PATLESL). A simulated annealing algorithm was used to select the optimal energy layers. Meanwhile, an adaptive spot assignment strategy was implemented using a spot-sparsity optimization algorithm based on the primal-dual active set with continuation to achieve an improved peak-to-valley dose ratio (PVDR). Subsequently, LET optimization was achieved using the alternating direction method of multipliers with a minimum monitor unit constraint. Eighteen patients were selected to evaluate plan quality and delivery efficiency compared with the lattice technique based on the previously reported spot-scanning proton arc therapy energy sequence optimization algorithm (PATseq). Feasibility and dosimetric accuracy were further validated using clinical phantom measurements. RESULTS: Compared with PATseq, the PATLESL plan exhibited improved dose and LET distributions with higher delivery efficiency. More specifically, PATLESL achieved steeper dose gradients, improving the PVDR from 16.90 ± 18.04 to 41.85 ± 29.69 (p < 0.01), shortening the beam delivery time by 37.43%, and increasing the target spot coverage by 44.12% while reducing the spot number by 93.78%. It also increased the mean LET in the LTV from 2.84 ± 0.38 to 3.59 ± 0.26 keV/μm (p < 0.01), on average. Meanwhile, the phantom measurement confirmed high agreement between the planned and delivered results. CONCLUSIONS: A novel PAT lattice technique using adaptive spot assignment and LET optimization could deliver an enhanced peak-valley spatial dose distribution. Experimental validation on a clinical proton system confirmed deliverability and dosimetric accuracy, which may facilitate future clinical translation of proton lattice radiotherapy.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.